The industry’s lobbying effort could blunt new competition to its products and reduce the savings anticipated in the federal health care overhaul.

Follow this link:
Battle in States on Generic Copies of Biotech Drugs
|
|
|||
|
Battle in States on Generic Copies of Biotech DrugsBy By ANDREW POLLACK, on January 29th, 2013 The industry’s lobbying effort could blunt new competition to its products and reduce the savings anticipated in the federal health care overhaul.
Follow this link: Share this:January 29th, 2013 | Tags: 'new, amgen inc|amgn|nasdaq, border, drugs (pharmaceuticals), fed, genentech inc, health car, health care, inventions and patents, law and legislation, petition, red | Category: Amgen Inc|AMGN|NASDAQ, Biotechnology, border, Drugs (Pharmaceuticals), Fed, Genentech Inc, GI, Health, health car, health care, industry, Inventions and Patents, Law and Legislation, new, News, petition, red, the Fed, TI, UC, UN, US Comments are closed. |
America, Inc. at it’s FinestLoading
|
|
|
heave-ho.org Copyright © 2013 heave-ho.org | all the news that's fit to click™ - All Rights Reserved Powered by WordPress & Atahualpa |
|||